InstrumentCube

Main products: GC-MS, CMOS Camera, Silt Density Index (SDI) Meter, Liquid Chromatograph (LC), LC-MS, CCD Camera, Sulfide Analyzer, Ion Chromatograph (IC), Infrared Thermal Imager, Video Microscope, Gene Sequencer, Single-Cell Analyzer, Water VOC Monitor, Preparative Liquid Chromatograph, UV Imager, Toolmaker's Microscope, Flow Cytometer, Electrophoresis System, Supercritical Fluid Chromatograph, PCR, High-Content Cell Imaging System, Metallurgical Microscope, Sulfur-Nitrogen Analyzer, Laser Confocal Microscope, NGS Library Prep Workstation, Stereo Microscope, Microscopic Image Analysis System, UV-Vis Spectrophotometer, Multi-Parameter Water Quality Analyzer

Gold Member Business License 21 Years in Business
Home/ News/ How Academician Zihe Rao's Team Uses NanoTemper Technology to Advance Quantitative Analysis in Structural Biology

How Academician Zihe Rao's Team Uses NanoTemper Technology to Advance Quantitative Analysis in Structural Biology

Aug 13, 2026•InstrumentCube

Featured Case Studies

For many procurement users, choosing a reliable and durable product from among the thousands of instrument brands of mixed quality on the market has always been a headache. To improve users’ selection efficiency and help them buy the “big brand, good instrument, excellent service” they desire, Category Pioneers focuses on highly competitive, fast-growing instrument categories and selects the domestic/imported TOP 5 brands in each sub-category for users.

Because Category Pioneers companies have long concentrated on a specific sub-market, continuously honing their production technology or processes, and have withstood the test of long-term use in the daily work of thousands of users, they ultimately rank at the forefront nationwide, or even globally, in single-product market share. Category Pioneers instruments have also earned much praise and usage feedback from users. Today we share the user insights on the NanoTemper Monolith X Biomolecular Interaction Detector, a Category Pioneer.

Academician Zihe Rao’s team uses NanoTemper interaction technology to overcome the hard problem of quantification in structural biology.

1. Foreword

Tuberculosis remains one of the major challenges facing the global public health field today. Mycobacterium tuberculosis has a structurally complex, lipid-rich cell wall; this “natural barrier” not only helps it resist external drug attacks, but also makes tuberculosis treatment cycles long, drug-resistance risks high and early diagnosis difficult. With the continuous emergence of drug-resistant M. tuberculosis strains, developing new anti-tuberculosis drugs and more sensitive and specific diagnostic tools has become a key scientific problem in tuberculosis prevention and control.

In Academician Zihe Rao’s research group, we have long worked with two key classes of membrane proteins — MmpL3 (a key channel for M. tuberculosis cell-wall synthesis) and LpqY-SugABC (a trehalose recycling system). These two lines of research sound quite different: the former points toward new anti-tuberculosis drugs, the latter toward live-bacteria diagnostic probes; but at the bench, we face the same difficulty: on the one hand, the target protein systems are complex, and the ligand molecules include both strongly hydrophobic small-molecule inhibitors and carbohydrate analogues bearing multiple hydroxyl groups or functional modifications; on the other hand, the samples require detergents, lipid nanodiscs and other environments to maintain their conformation. Traditional interaction-detection methods are easily limited by immobilization, large sample consumption, or insufficient system compatibility.

2. Research Content

Case 1: MmpL3 — A Key Channel for M. tuberculosis Cell-Wall Synthesis

MmpL3 is an essential membrane transporter in M. tuberculosis, mainly responsible for transporting cell-wall precursors such as trehalose monomycolate from the inner side of the cell membrane to the outer side. This process relies on the proton-motive force and is a key step in the synthesis of the M. tuberculosis cell wall. Once the function of MmpL3 is blocked, the cell-wall synthesis of M. tuberculosis will be disrupted, thereby affecting its growth and survival.

The research team studied and resolved the complex structures of MmpL3 with multiple classes of inhibitors, including compounds such as NITD-349, SPIRO and ST004 obtained by structure-guided design. The results showed that, although these compounds have different chemical scaffolds, they can all bind near the central channel of the MmpL3 transmembrane region, blocking the proton-driven substrate transport process by affecting the key Asp-Tyr proton-transfer network.

This type of research not only explains the shared mechanism of action of multiple classes of MmpL3 inhibitors, but also provides a structural basis for the subsequent rational design of anti-tuberculosis drugs: by optimizing the hydrophobic and hydrogen-bonding interactions of inhibitors at different sub-sites, it is expected that more efficient and more selective anti-tuberculosis drug candidates can be obtained.

Figure caption: Mechanistic model of an MmpL3 inhibitor binding to the central channel of the transmembrane region and blocking proton-driven transport.

Case 2: LpqY-SugABC — A Potential Entry Point for Diagnostic Probes in M. tuberculosis

Unlike MmpL3, which points toward drug development, the LpqY-SugABC system shows another important application path: using the trehalose recycling system unique to M. tuberculosis to develop live-bacteria detection and imaging probes.

Trehalose is a core molecule in the synthesis of cell-wall glycolipids in M. tuberculosis. During the synthesis of important glycolipids such as trehalose monomycolate, M. tuberculosis releases trehalose; subsequently, the LpqY-SugABC system is responsible for recycling the trehalose back into the cytoplasm. The research resolved the structure of the complex of M. tuberculosis LpqY-SugABC bound with trehalose by cryo-electron microscopy, and further obtained the crystal structures of LpqY bound with a variety of trehalose analogues. The structures show that LpqY recognizes trehalose in a closed conformation similar to a “Venus flytrap,” with the two glucose units stabilized through interactions with multiple key residues, including Arg421, Asp97, Glu258, Asn151, Gln76, Thr42, Asp43 and Trp276, among others. The multiple hydroxyl groups of trehalose participate in the hydrogen-bonding network, ensuring highly specific recognition.

More importantly, the substrate-binding pocket of LpqY is not completely rigid but has a certain plasticity. The research found that 6-TreAz, 6,6′-difluoro-trehalose, 6,6′-diazido-trehalose, and trehalose analogues bearing larger substituents can still be recognized by LpqY to varying degrees. This means that researchers can introduce fluorescent groups, azide groups or other functional groups onto the trehalose scaffold, turning it into a molecular probe capable of entering M. tuberculosis and labeling the live-bacterial state.

This finding provides a new idea for tuberculosis diagnosis: unlike simply detecting nucleic acids or antigens, the subsequent development of trehalose-analogue probes is expected to exploit the bacterium’s own sugar-metabolism pathway to achieve specific labeling and imaging of live bacteria, thereby serving early diagnosis, drug-efficacy evaluation and infection-process research.

Figure caption: LpqY recognizes trehalose, providing the structural basis for diagnostic probes to enter M. tuberculosis.

3. How Does MST Technology Provide the Key Quantitative “Chain of Evidence” for Interactions?

In research on membrane proteins and substrate-binding proteins such as MmpL3 and LpqY, the common difficulty we face is: the target protein systems are complex, and the ligand molecules include both strongly hydrophobic small-molecule inhibitors and carbohydrate analogues bearing multiple hydroxyl groups or functional modifications; at the same time, membrane-protein samples often need detergents, lipid nanodiscs and other environments to maintain a stable conformation, and traditional interaction-detection methods are easily limited by immobilization, large sample consumption, or insufficient system compatibility.

MicroScale Thermophoresis (MST) provided important quantitative interaction evidence in these studies.

For the MmpL3 inhibitor research, MST directly measured the binding affinity of the small-molecule compound with MmpL3, with a Kd of about 9.58 µM, and, combined with drug-sensitivity experiments on MmpL3-overexpressing strains and the cryo-EM structures, jointly established a complete chain of evidence of “compound binding — target validation — structure resolution — antibacterial activity.”

Figure caption: The chain of evidence.

For the LpqY-SugABC system, MST is likewise suitable for evaluating the binding ability of trehalose and its analogues to LpqY. This type of research not only needs to know whether a given analogue can be recognized by LpqY, but also needs to further compare the effects of different modifying groups on the binding affinity and transport potential. MST can complete protein–small-molecule interaction detection in the solution state, avoiding the conformational interference that immobilization may bring. Combined with crystal structures, cryo-EM structures and substrate-stimulated ATPase activity experiments, it forms a complementary interpretation: structural resolution shows “how the molecule is recognized,” MST quantification shows “how the binding strength differs,” and ATPase activity further indicates “whether such binding may drive transport.”

4. Practical Experience: Why Did We Choose NanoTemper MST Technology?

Looking back on the entire research process, we chose the MST and label-free technologies provided by NanoTemper for the interaction-detection step mainly out of several practical considerations:

Click to view more details on the NanoTemper Monolith X Biomolecular Interaction Detector

First, solution-state detection. The conformation of membrane-protein systems is extremely sensitive to the environment; being able to directly detect protein-ligand interactions in solution avoids the non-specific binding or conformational distortion that immobilization may introduce, which was a very key decision factor for us when comparing different detection methods.

Second, low sample consumption. The expression and purification of membrane proteins are not easy in themselves, and preparing uniform samples especially in a nanodisc or detergent environment is even more time-consuming. MST requires very little protein, enabling us to complete multiple sets of parallel comparison experiments under limited sample conditions.

Third, method flexibility. Whether the ligand is a small-molecule inhibitor or a carbohydrate analogue bearing modifying groups, MST is compatible with it. Moreover, detection can be performed either through fluorescent labeling or directly using the protein’s own fluorescence, further reducing sample-processing steps.

Fourth, fast detection speed. When multiple ligands or multiple concentration gradients need to be tested, the high-throughput experimental efficiency significantly shortens the time period from experimental design to obtaining reliable data.

For laboratories that take membrane proteins as their research object, these features are very practical advantages when choosing an interaction-detection tool. It is precisely because of the support of reliable quantitative interaction data that we can, on the basis of structural discoveries, build a complete research logic from molecular recognition to functional verification.

As scientific research users, we look forward to NanoTemper continuing, in the future, to use its stable, sensitive and low-sample-consumption biomolecular interaction technology platform to help more research on pathogenic microorganisms, membrane-protein drug targets and diagnostic-probe development achieve breakthroughs.

Introduction to the First Author and the Research Group

Tianyu Hu, Ph.D., ShanghaiTech University

A postdoctoral researcher in the Zihe Rao group at ShanghaiTech University, he works on research into M. tuberculosis and transporters related to lipid transport and nutrient uptake, and has published multiple papers in international journals such as Sci Adv, Nat Struct Mol Biol and Structure. Academician Zihe Rao’s team has long been engaged in research on the molecular mechanisms of important pathogens such as influenza virus, coronavirus, HIV and M. tuberculosis, as well as the related development of vaccines, neutralizing antibodies and small-molecule drugs. It has published more than 480 peer-reviewed papers in international scientific journals, including 32 research papers in the main journals of the three major science magazines Cell, Nature and Science, and has been cited more than 43,100 times.

References

Hu T, Yang X, Liu F, Sun S, Xiong Z, Liang J, Yang X, Wang H, Yang X, Guddat LW, Yang H, Rao Z, Zhang B. Structure-based design of anti-mycobacterial drug leads that target the mycolic acid transporter MmpL3. Structure. 2022 Oct 6;30(10):1395-1402.e4. doi: 10.1016/j.str.2022.07.009

Yang X, Hu T, Yang X, Xu W, Yang H, Guddat LW, Zhang B, Rao Z. Structural Basis for the Inhibition of Mycobacterial MmpL3 by NITD-349 and SPIRO. J Mol Biol. 2020 Jul 24;432(16):4426-4434. doi: 10.1016/j.jmb.2020.05.019

Liang J, Liu F, Xu P, Shangguan W, Hu T, Wang S, Yang X, Xiong Z, Yang X, Guddat LW, Yu B, Rao Z, Zhang B. Molecular recognition of trehalose and trehalose analogues by Mycobacterium tuberculosis LpqY-SugABC. Proc Natl Acad Sci U S A. 2023 Aug 29;120(35):e2307625120. doi: 10.1073/pnas.2307625120

Click to view the new NanoTemper multifunctional biomolecular interaction and stability analyzer, Monolith Omni

For reliable instruments, use [Instrument Select] — the professional purchasing guide platform for scientific instruments; click to view: #Biomolecular Interaction Analyzer

View More from This Booth